Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1979 1
1980 1
1981 2
1982 1
1983 3
1984 2
1985 4
1986 1
1988 3
1989 7
1990 5
1991 5
1992 4
1993 7
1994 7
1995 11
1996 11
1997 6
1998 8
1999 5
2000 11
2001 9
2002 7
2003 12
2004 17
2005 17
2006 19
2007 22
2008 35
2009 25
2010 30
2011 46
2012 45
2013 49
2014 60
2015 54
2016 59
2017 68
2018 67
2019 91
2020 119
2021 163
2022 169
2023 200
2024 166
2025 178
2026 31

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,659 results

Results by year

Filters applied: . Clear all
Page 1
Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell and tumor-localized IL-12 immunotherapy.
Bhatia V, Kamat NV, Pariva TE, Wu LT, Tsao A, Sasaki K, Sun H, Javier G, Nutt S, Coleman I, Hitchcock L, Zhang A, Rudoy D, Gulati R, Patel RA, Roudier MP, True LD, Srivastava S, Morrissey CM, Haffner MC, Nelson PS, Priceman SJ, Ishihara J, Lee JK. Bhatia V, et al. Nat Commun. 2023 Apr 11;14(1):2041. doi: 10.1038/s41467-023-37874-2. Nat Commun. 2023. PMID: 37041154 Free PMC article.
Six transmembrane epithelial antigen of the prostate 1 (STEAP1) is a cell surface antigen for therapeutic targeting in prostate cancer. Here, we report broad expression of STEAP1 relative to prostate-specific membrane antigen (PSMA) in lethal metastatic prostate cancers …
Six transmembrane epithelial antigen of the prostate 1 (STEAP1) is a cell surface antigen for therapeutic targeting in prostate cancer …
Cannabis-based medicines and medical cannabis for adults with cancer pain.
Häuser W, Welsch P, Radbruch L, Fisher E, Bell RF, Moore RA. Häuser W, et al. Cochrane Database Syst Rev. 2023 Jun 5;6(6):CD014915. doi: 10.1002/14651858.CD014915.pub2. Cochrane Database Syst Rev. 2023. PMID: 37283486 Free PMC article. Review.
Analyses of tolerability and safety were not possible for these studies. There was low-certainty evidence that CBD oil did not add value to specialist palliative care alone in the reduction of pain intensity in people with advanced cancer. ...There is low-certainty …
Analyses of tolerability and safety were not possible for these studies. There was low-certainty evidence that CBD oil did not add va …
Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain.
Johnson JR, Burnell-Nugent M, Lossignol D, Ganae-Motan ED, Potts R, Fallon MT. Johnson JR, et al. J Pain Symptom Manage. 2010 Feb;39(2):167-79. doi: 10.1016/j.jpainsymman.2009.06.008. Epub 2009 Nov 5. J Pain Symptom Manage. 2010. PMID: 19896326 Free article. Clinical Trial.
This study compared the efficacy of a tetrahydrocannabinol:cannabidiol (THC:CBD) extract, a nonopioid analgesic endocannabinoid system modulator, and a THC extract, with placebo, in relieving pain in patients with advanced cancer. ...However, the results from the Eu …
This study compared the efficacy of a tetrahydrocannabinol:cannabidiol (THC:CBD) extract, a nonopioid analgesic endocannabinoid syste …
CBD Inhibits In Vivo Development of Human Breast Cancer Tumors.
García-Morales L, Mendoza-Rodríguez MG, Tapia Ramírez J, Meza I. García-Morales L, et al. Int J Mol Sci. 2023 Aug 26;24(17):13235. doi: 10.3390/ijms241713235. Int J Mol Sci. 2023. PMID: 37686042 Free PMC article.
Inflammation is a critical component of cancer development. Previously, we showed in vitro that IL-1beta treatment of non-invasive human breast cancer MCF-7 cells promoted their transition to a malignant phenotype (6D cells). ...These results confirm that in vivo …
Inflammation is a critical component of cancer development. Previously, we showed in vitro that IL-1beta treatment of non-invasive hu …
Crowdfunding Cannabidiol (CBD) for Cancer: Hype and Misinformation on GoFundMe.
Zenone M, Snyder J, Caulfield T. Zenone M, et al. Am J Public Health. 2020 Oct;110(S3):S294-S299. doi: 10.2105/AJPH.2020.305768. Am J Public Health. 2020. PMID: 33001729 Free PMC article.
To use crowdfunding campaigns to better understand how cannabidiol (CBD) is represented (and misrepresented) as cancer-related care.Methods. We analyzed CBD-related crowdfunding campaigns (n = 155) created between January 2017 and May 2019 in multiple countri …
To use crowdfunding campaigns to better understand how cannabidiol (CBD) is represented (and misrepresented) as cancer-related …
Cannabinoids: Therapeutic Use in Clinical Practice.
Pagano C, Navarra G, Coppola L, Avilia G, Bifulco M, Laezza C. Pagano C, et al. Int J Mol Sci. 2022 Mar 19;23(6):3344. doi: 10.3390/ijms23063344. Int J Mol Sci. 2022. PMID: 35328765 Free PMC article. Review.
Today, FDA-approved drugs, such as nabiximols (a mixture of THC and non-psychoactive cannabidiol (CBD)), are employed in alleviating pain and spasticity in multiple sclerosis. Dronabinol and nabilone are used for the treatment of chemotherapy-induced nausea and vomiting in …
Today, FDA-approved drugs, such as nabiximols (a mixture of THC and non-psychoactive cannabidiol (CBD)), are employed in alleviating …
Exosomal delivery of cannabinoids against cancer.
Kaur S, Nathani A, Singh M. Kaur S, et al. Cancer Lett. 2023 Jul 10;566:216243. doi: 10.1016/j.canlet.2023.216243. Epub 2023 May 29. Cancer Lett. 2023. PMID: 37257632 Free PMC article. Review.
Currently, Delta-9-tetrahydrocannabinol (THC), cannabidiol (CBD) and other cannabinoids (e.g., CBG, THCV, CBC), are being explored for their anticancer and anti-proliferative properties. ...More extensively, we culminate information available on different sources of EVs th …
Currently, Delta-9-tetrahydrocannabinol (THC), cannabidiol (CBD) and other cannabinoids (e.g., CBG, THCV, CBC), are being explored fo …
[Cannabidiol in cancer treatment].
Likar R, Köstenberger M, Nahler G. Likar R, et al. Schmerz. 2020 Apr;34(2):117-122. doi: 10.1007/s00482-019-00438-9. Schmerz. 2020. PMID: 31897700 Review. German.
BACKGROUND: Cannabis was used for cancer patients as early as about 2500 years ago. Experimental studies demonstrated tumor-inhibiting activities of various cannabinoids more than 40 years ago. In view of the status of tetrahydrocannabinol (THC) as a regulated substance, n …
BACKGROUND: Cannabis was used for cancer patients as early as about 2500 years ago. Experimental studies demonstrated tumor-inhibitin …
CBD: a biomarker database for colorectal cancer.
Zhang X, Sun XF, Cao Y, Ye B, Peng Q, Liu X, Shen B, Zhang H. Zhang X, et al. Database (Oxford). 2018 Jan 1;2018:bay046. doi: 10.1093/database/bay046. Database (Oxford). 2018. PMID: 29846545 Free PMC article.
Colorectal cancer (CRC) biomarker database (CBD) was established based on 870 identified CRC biomarkers and their relevant information from 1115 original articles in PubMed published from 1986 to 2017. ...They can submit their new findings to our database via the su …
Colorectal cancer (CRC) biomarker database (CBD) was established based on 870 identified CRC biomarkers and their relevant inf …
Cannabidiol and Other Phytocannabinoids as Cancer Therapeutics.
Nahler G. Nahler G. Pharmaceut Med. 2022 Apr;36(2):99-129. doi: 10.1007/s40290-022-00420-4. Epub 2022 Mar 4. Pharmaceut Med. 2022. PMID: 35244889 Free PMC article. Review.
Preclinical models provided ample evidence that cannabinoids are cytotoxic against cancer cells. Among the best studied phytocannabinoids, cannabidiol (CBD) is most promising for the treatment of cancer as it lacks the psychotomimetic properties of delta-9-te …
Preclinical models provided ample evidence that cannabinoids are cytotoxic against cancer cells. Among the best studied phytocannabin …
1,659 results